ARES-PB Financials

ARES-PB

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows ARES-PB (ARES-PB) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 14 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI ARES-PB FY2025 2026-04-22

Cash generation has flipped from balance-sheet drain to source, while leverage is being dialed down across the capital structure.

Over the recent period, return on assets held near 1.8% even as debt-to-equity nearly halved. Return on equity still fell to 12.3%, which shows the business is earning a similar rate on its asset base but is relying less on thin equity and heavy leverage to magnify shareholder returns.

Cash conversion changed sharply: operating cash flow moved from -$233M to $3.27B over the last two years. With net income staying in the same general range, cash availability is now being shaped far more by balance-sheet release and other non-earnings drivers than by reported profit alone.

Dividends and expansion both matter to this capital structure: dividends paid were $2.60B, and goodwill reached $3.45B. That mix says surplus cash is being sent out to investors while a bigger slice of the asset base comes from acquired businesses, so reported asset growth is not the same thing as organic balance-sheet buildup.

Financial Health Signals

Financial Profile 20/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of ARES-PB's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Growth

ARES-PB's revenue surged 28.9% year-over-year to $4.8B, reflecting rapid business expansion. This strong growth earns a score of 69/100.

Leverage

ARES-PB has elevated debt relative to equity (D/E of 4.66), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 7/100, reflecting increased financial risk.

Returns

ARES-PB's ROE of 12.3% shows moderate profitability relative to equity, earning a score of 45/100. This is down from 13.1% the prior year.

Piotroski F-Score Neutral

4/9

ARES-PB passes 4 of 9 financial strength tests. 3 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.

Earnings Quality Cash-Backed

6.19x

For every $1 of reported earnings, ARES-PB generates $6.19 in operating cash flow ($3.3B OCF vs $527.4M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$4.8B

YoY+28.9%

5Y CAGR+22.1%

10Y CAGR+19.3%

ARES-PB generated $4.8B in revenue in fiscal year 2025. This represents an increase of 28.9% from the prior year.

EBITDA

N/A

Net Income

$527.4M

YoY+13.7%

5Y CAGR+28.2%

10Y CAGR+39.1%

ARES-PB reported $527.4M in net income in fiscal year 2025. This represents an increase of 13.7% from the prior year.

EPS (Diluted)

N/A

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$488.9M

YoY-67.6%

5Y CAGR-2.0%

ARES-PB held $488.9M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

N/A

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

11.1%

YoY-1.5pp

5Y CAGR+2.4pp

10Y CAGR+8.7pp

ARES-PB's net profit margin was 11.1% in fiscal year 2025, showing the share of revenue converted to profit. This is down 1.5 percentage points from the prior year.

Return on Equity

12.3%

YoY-0.8pp

5Y CAGR-0.4pp

10Y CAGR+4.5pp

ARES-PB's ROE was 12.3% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 0.8 percentage points from the prior year.

Capital Allocation

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

N/A

ARES-PB Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$4.8B+28.9%	$3.7B+14.0%	$3.2B+12.4%	$2.9B-31.6%	$4.2B+140.2%	$1.8B
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$996.1M+35.2%	$736.5M+11.6%	$660.1M-5.0%	$695.3M+56.5%	$444.2M+71.5%	$259.0M
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	N/A	N/A	N/A	$71.4M+94.1%	$36.8M+47.6%	$24.9M
Income Tax	$198.5M+20.6%	$164.6M-4.8%	$173.0M+140.6%	$71.9M-51.2%	$147.4M+168.0%	$55.0M
Net Income	$527.4M+13.7%	$463.7M-2.2%	$474.3M+183.1%	$167.5M-59.0%	$408.8M+168.7%	$152.1M
EPS (Diluted)	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Revenue	$1.1B-36.5%	$1.7B+59.3%	$1.0B+3.6%	$1.0B+5.7%	$950.2M-15.9%	$1.1B+29.1%	$874.9M+18.9%	$735.8M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$289.9M+17.8%	$246.2M+6.0%	$232.2M+1.9%	$227.9M+14.5%	$199.1M+1.1%	$197.0M+16.3%	$169.4M-0.9%	$170.9M
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	$8.1M-92.7%	$111.9M+83.6%	$61.0M+247.6%	$17.5M-64.8%	$49.9M+7.3%	$46.5M+13.1%	$41.1M+50.8%	$27.2M
Net Income	$54.2M-81.2%	$288.9M+110.8%	$137.1M+190.6%	$47.2M-73.4%	$177.3M+49.7%	$118.5M+24.8%	$94.9M+30.0%	$73.0M
EPS (Diluted)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

ARES-PB Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$28.6B+15.1%	$24.9B+0.6%	$24.7B+12.4%	$22.0B+1.8%	$21.6B+42.4%	$15.2B
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$488.9M-67.6%	$1.5B+333.0%	$348.3M-10.7%	$390.0M+13.5%	$343.7M-36.3%	$539.8M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	$3.5B+197.1%	$1.2B+3.4%	$1.1B+12.4%	$999.7M+26.9%	$788.0M+112.4%	$371.0M
Total Liabilities	$19.9B+14.0%	$17.5B-11.3%	$19.7B+15.3%	$17.1B+2.4%	$16.7B+32.5%	$12.6B
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$4.3B+20.7%	$3.5B+87.2%	$1.9B+19.1%	$1.6B-12.9%	$1.8B+52.9%	$1.2B
Retained Earnings	-$1.5B-73.4%	-$837.3M-69.1%	-$495.1M-34.0%	-$369.5M-313.4%	-$89.4M+41.1%	-$151.8M

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Total Assets	$28.6B+5.9%	$27.0B-0.9%	$27.3B+0.3%	$27.2B+9.2%	$24.9B+1.5%	$24.5B+1.4%	$24.2B-0.9%	$24.4B
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$488.9M-1.6%	$496.7M-2.5%	$509.7M-17.6%	$618.5M-59.0%	$1.5B+330.7%	$350.1M+23.1%	$284.4M-17.9%	$346.3M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	$3.5B+0.5%	$3.4B0.0%	$3.4B-1.8%	$3.5B+201.0%	$1.2B+2.6%	$1.1B+0.2%	$1.1B0.0%	$1.1B
Total Liabilities	$19.9B+8.3%	$18.4B-0.1%	$18.4B+0.2%	$18.4B+5.2%	$17.5B-6.2%	$18.6B+1.1%	$18.4B-4.9%	$19.4B
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$4.3B-4.4%	$4.5B+2.6%	$4.4B-2.1%	$4.5B+25.7%	$3.5B+70.7%	$2.1B+3.7%	$2.0B+13.3%	$1.8B
Retained Earnings	-$1.5B-19.2%	-$1.2B+0.2%	-$1.2B-13.7%	-$1.1B-28.3%	-$837.3M-5.7%	-$792.4M-11.2%	-$712.9M-16.4%	-$612.6M

ARES-PB Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$3.3B+17.0%	$2.8B+1296.6%	-$233.3M+68.2%	-$734.1M+71.7%	-$2.6B-509.9%	-$425.7M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	-$1.8B-1031.5%	-$159.4M-43.5%	-$111.1M+67.1%	-$337.4M+68.9%	-$1.1B-693.1%	-$136.8M
Financing Cash Flow	-$2.4B-69.5%	-$1.4B-590.1%	$292.1M-74.1%	$1.1B-67.8%	$3.5B+271.2%	$943.9M
Dividends Paid	$2.6B+78.4%	$1.5B+29.1%	$1.1B	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Operating Cash Flow	-$483.7M-136.1%	$1.3B+222.5%	$415.7M-79.2%	$2.0B+146.9%	$807.6M-4.0%	$841.3M+94.7%	$432.2M-39.1%	$710.0M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	-$21.1M-41.0%	-$15.0M+34.8%	-$22.9M+98.7%	-$1.7B-2646.8%	-$63.5M-95.0%	-$32.6M-11.4%	-$29.2M+14.2%	-$34.1M
Financing Cash Flow	$542.9M+144.3%	-$1.2B-116.0%	-$567.2M+51.8%	-$1.2B-346.3%	$478.2M+161.0%	-$784.2M-70.9%	-$458.9M+31.2%	-$666.6M
Dividends Paid	$21.0M-0.3%	$21.1M+0.7%	$21.0M-2.5%	$21.5M+33.5%	$16.1M-0.9%	$16.2M+1.5%	$16.0M-1.8%	$16.3M
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

ARES-PB Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	11.1%-1.5pp	12.6%-2.1pp	14.7%+8.8pp	5.8%-3.9pp	9.7%+1.0pp	8.7%
Return on Equity	12.3%-0.8pp	13.1%-12.0pp	25.1%+14.5pp	10.5%-11.9pp	22.4%+9.7pp	12.8%
Return on Assets	1.8%-0.0pp	1.9%-0.1pp	1.9%+1.2pp	0.8%-1.1pp	1.9%+0.9pp	1.0%
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	4.66-0.3	4.93-5.5	10.41-0.3	10.76+1.6	9.15-1.4	10.55
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	5.1%-12.3pp	17.4%+4.3pp	13.2%+8.5pp	4.7%-14.0pp	18.7%+8.2pp	10.5%-0.4pp	10.8%+0.9pp	9.9%
Return on Equity	1.3%-5.2pp	6.5%+3.3pp	3.1%+2.1pp	1.1%-3.9pp	5.0%-0.7pp	5.7%+1.0pp	4.7%+0.6pp	4.1%
Return on Assets	0.2%-0.9pp	1.1%+0.6pp	0.5%+0.3pp	0.2%-0.5pp	0.7%+0.2pp	0.5%+0.1pp	0.4%+0.1pp	0.3%
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	4.66+0.5	4.11-0.1	4.22+0.1	4.13-0.8	4.93-4.0	8.98-0.2	9.21-1.8	10.97
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Frequently Asked Questions

What is ARES-PB's annual revenue?

ARES-PB (ARES-PB) reported $4.8B in total revenue for fiscal year 2025. This represents a 28.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is ARES-PB's revenue growing?

ARES-PB (ARES-PB) revenue grew by 28.9% year-over-year, from $3.7B to $4.8B in fiscal year 2025.

Is ARES-PB profitable?

Yes, ARES-PB (ARES-PB) reported a net income of $527.4M in fiscal year 2025, with a net profit margin of 11.1%.

What is ARES-PB's net profit margin?

ARES-PB (ARES-PB) had a net profit margin of 11.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is ARES-PB's return on equity (ROE)?

ARES-PB (ARES-PB) has a return on equity of 12.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is ARES-PB's operating cash flow?

ARES-PB (ARES-PB) generated $3.3B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are ARES-PB's total assets?

ARES-PB (ARES-PB) had $28.6B in total assets as of fiscal year 2025, including both current and long-term assets.

What is ARES-PB's debt-to-equity ratio?

ARES-PB (ARES-PB) had a debt-to-equity ratio of 4.66 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is ARES-PB's return on assets (ROA)?

ARES-PB (ARES-PB) had a return on assets of 1.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is ARES-PB's Piotroski F-Score?

ARES-PB (ARES-PB) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are ARES-PB's earnings high quality?

ARES-PB (ARES-PB) has an earnings quality ratio of 6.19x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is ARES-PB?

ARES-PB (ARES-PB) scores 20 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.